TY  - GEN
AU  - Faxon,D P
TI  - Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group
SN  - 0735-1097
PY  - 1995///0222
KW  - Angioplasty, Balloon, Coronary
KW  - Aspirin
KW  - therapeutic use
KW  - Cilazapril
KW  - administration & dosage
KW  - Coronary Angiography
KW  - Coronary Disease
KW  - diagnostic imaging
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Linear Models
KW  - Male
KW  - Middle Aged
KW  - Recurrence
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/0735-1097(94)00368-z
ER  -